Re:Psilocybin for major depression granted Breakthrough Ther...
by gbrown on Tuesday November 26, 2019 @10:21AM
(#21639000)
You don't - you compare it to "standard of care" (antidepressants, CBT, etc.).
If we can compare an inferior treatment to placebo, and we can compare a breakthrough treatment to this established standard, we can evaluate the new treatment.
If we can compare an inferior treatment to placebo, and we can compare a breakthrough treatment to this established standard, we can evaluate the new treatment.